Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. Devices plus drugs may mean an earlier payoff
Med-tech makers could see an earlier payoff by looking at ways to deliver drug therapy with their devices, MIT researcher Michael Cima said.
2. Sapien transapical trial spiked on adverse events
A clinical trial examining the insertion of Edwards Lifesciences’ Sapien heart valve through the ribcage gets cut short after several patients experience stroke, kidney failure and death.
1. Baxter CEO Parkinson cashes in, reaps $14 million
Robert Parkinson Jr., chairman & CEO of Baxter International (NYSE:BAX), added 20 percent to his paycheck total from last year by cashing in on stock options for the first time.
